Building Blocks

Fmoc-His(Trt)-OH is an amino acid with the chemical formula HOOC-CH2-CH2-N(CH3)2. It has broad-spectrum antimicrobial activity and can be used as a chemosensor for trifluoroacetic acid. Fmoc-His(Trt)-OH also showed anticancer activity, which may be due to its ability to inhibit protein synthesis in cancer cells by inhibiting histidine decarboxylase. Fmoc-His(Trt)-OH is synthesized through a chemical reaction using trifluoroacetic acid, which reacts with His and Trt residues on the surface of the resin.

5-Bromo-2-nitrobenzoic acid is a chemical compound that belongs to the group of bromonitrobenzenes. It is an important intermediate in organic chemistry and has been used as a reagent for the synthesis of various heterocyclic compounds. 5-Bromo-2-nitrobenzoic acid can be used as a building block for pharmaceuticals, agrochemicals, dyes, and other chemicals. This versatile chemical has been widely used in research and development as a reaction component for synthesizing pharmaceuticals or speciality chemicals or as a building block to produce useful scaffolds.

5-Bromo-2,4-dichloropyrimidine is an aryl halide compound that is synthesized from 2,4-dichloropyrimidine and bromine. It has been shown to have inhibitory activities against cancer cells in vitro. 5-Bromo-2,4-dichloropyrimidine is used in the synthesis of the drug palbociclib (also known as PLX4720), which prevents mitotic progression by binding to the mitotic checkpoint protein (e.g., cyclin B). The reaction yield for this compound is low and its absorption enhancer properties are not well understood. 5-Bromo-2,4-dichloropyrimidine has also been used in conjunction with crotonic acid as a potential anticancer agent.

5-Bromo-7-azaindole is a nitrogen heterocycle that has shown promising anti-cancer properties. This compound is synthesized by the reaction of sodium azide and 5-bromo-2,4,6-trinitrobenzene in anhydrous conditions. 5-Bromo-7-azaindole displays significant cytotoxicity against human ovarian carcinoma cells in vivo and inhibits the proliferation of cancer cells by binding to ATP synthase. The anticancer activity of this compound is due to its ability to inhibit the synthesis of DNA and RNA, which are vital for cell division. 5-Bromo-7-azaindole also shows an increase in hydrogen bonding, which can be used to explain its structural analysis.

Please enquire for more information about 3-Chloro-5-hydroxybenzoic acid ethyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page

Intermediate in organic synthesis

Versatile small molecule scaffold

2,6-Dinitro-4-methylaniline is an amide that has been shown to induce cancer in animals. It has a high affinity for nucleic acids and forms covalent bonds with DNA. 2,6-Dinitro-4-methylaniline is metabolized by the liver and excreted by the kidneys into urine, where it can be detected in urine samples. This compound has been shown to bioconcentrate in organisms and accumulate in tissues as well as activate radiation. The activation of this compound is dose dependent and may be due to its ability to form covalent bonds with DNA.

3,4-Dimethoxybenzylamine is an amine that is used in the synthesis of pharmaceuticals. It can be polymerized by heating with aqueous formaldehyde and hydrochloric acid to form a resin. 3,4-Dimethoxybenzylamine inhibits serotonin receptors, exhibiting inhibitory properties at concentrations of 10-5 M. 3,4-Dimethoxybenzylamine also has pharmacokinetic properties that are similar to vitamin B1. This compound has been shown to inhibit homogeneous catalysts and is used for coatings for ganglion cells.

Tak-659 is an amide compound that inhibits the serine protease activity of a number of enzymes, including cathepsin B and L. Tak-659 has been shown to have inhibitory effects on inflammation in animal models by inhibiting the production of inflammatory cytokines. Tak-659 has also been shown to impair protein synthesis in gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa. The mechanism for this inhibition is not entirely clear but may be due to tak-659 binding to the ribosomal RNA near the peptidyl transferase center, blocking the entry of amino acids into the ribosome. Tak-659 binds with high affinity to adenosine receptors and has been shown to reduce levels of inflammatory cytokines in mouse tumor cells.